ICAM1 and glioblastoma: These effects, mediated by an AMPK-dependent intercellular adhesion molecule-1 (ICAM-1) may counteract glioblastoma progression, by alleviating the pro-inflammatory microenvironment and protecting the vascular compartment, also involved in angiogenesis [83].